These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15516698)

  • 21. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes and ACE inhibitors.
    Boulton AJ; Gokal R
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetic nephropathy.
    Castellino P; Tuttle KR; DeFronzo RA
    Curr Ther Endocrinol Metab; 1994; 5():426-36. PubMed ID: 7704768
    [No Abstract]   [Full Text] [Related]  

  • 24. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S
    J Assoc Physicians India; 1995 Jul; 43(7):517-8. PubMed ID: 8713236
    [No Abstract]   [Full Text] [Related]  

  • 25. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Lewis EJ; Lewis JB
    J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
    [No Abstract]   [Full Text] [Related]  

  • 26. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P
    Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141
    [No Abstract]   [Full Text] [Related]  

  • 27. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany.
    Adarkwah CC; Gandjour A
    Int J Technol Assess Health Care; 2010 Jan; 26(1):62-70. PubMed ID: 20059782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
    Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological prevention and treatment of diabetic nephropathy].
    Aitio ML
    Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
    [No Abstract]   [Full Text] [Related]  

  • 32. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renal histopathology of diabetic nephropathy].
    Suzuki Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():314-9. PubMed ID: 15999726
    [No Abstract]   [Full Text] [Related]  

  • 34. Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy.
    Cziraky MJ; Mehra IV; Wilson MD; Bakris GL
    Ann Pharmacother; 1996; 30(7-8):791-801. PubMed ID: 8826564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Blankfield RP
    N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11870250
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension in patients with type 2 diabetes.
    Weir MR
    Hosp Pract (1995); 2001 Jan; 36(1):41-2, 47-8, 51-4; discussion 54. PubMed ID: 11197942
    [No Abstract]   [Full Text] [Related]  

  • 37. Renoprotective role of ACE inhibitors in diabetic nephropathy.
    Mogensen CE
    Br Heart J; 1994 Sep; 72(3 Suppl):S38-45. PubMed ID: 7946802
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.
    Golan L; Birkmeyer JD; Welch HG
    Ann Intern Med; 1999 Nov; 131(9):660-7. PubMed ID: 10577328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive drugs and diabetic nephropathy.
    Mehler PS; Schrier RW
    Curr Hypertens Rep; 1999; 1(2):170-7. PubMed ID: 10981062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.